Pharmaline SRL
2.0 FTEThe score of Pharmaline shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -23 % Total assets -26 % Headcount (avg FTE) +5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmaline's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 31 Jul 2022
Pharmaline's financial analysis
- Solvency1.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmaline
Pharmaline's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0428.751.579
- VAT number
- BE0428751579
- Peppol
- Registered · 0208:0428751579 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Mar 1986
- Registered office
- 6183 Courcelles
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 24 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmaline (SRL) has been based in Courcelles since 1986, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 48,353 € and equity of 6,388 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 1.9%, below the median of its sector (41.5%).
Companies similar to Pharmaline
Companies in the same business, of comparable size and area, outside its group.
- Nathypharm Retail sale of pharmaceutical products Andenne · balance sheet 340,634 €
- Apotheek Yves Tarnaud Retail sale of pharmaceutical products Antwerp · balance sheet 338,407 €
- Pharma pour Tous Namur Retail sale of pharmaceutical products Namur · balance sheet 340,936 €
- Sogephar Retail sale of pharmaceutical products Ixelles · balance sheet 337,204 €
- Alsempharma Retail sale of pharmaceutical products Beersel · balance sheet 336,894 €
- Phardec Retail sale of pharmaceutical products Koekelberg · balance sheet 335,635 €
- Apoteek DE Smedt Retail sale of pharmaceutical products Asse · balance sheet 343,684 €
- Almax Pharma Retail sale of pharmaceutical products Walcourt · balance sheet 346,656 €
Frequently asked questions about Pharmaline
What is the revenue of Pharmaline?
Pharmaline files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmaline?
In Belgium, the VAT number is the company number prefixed with BE: BE0428751579 for Pharmaline, if the company is VAT-registered. Its company number (CBE) is 0428.751.579.
Where is the registered office of Pharmaline?
According to the CBE register, the registered office of Pharmaline is in 6183 Courcelles.
What is the equity of Pharmaline?
At the close of the 2025 financial year, the equity of Pharmaline amounts to 6,388 €, a solvency of 1.9% of total assets.
How many people work at Pharmaline?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmaline?
The register lists 2 active mandates at Pharmaline. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmaline
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →